References
- Hurley R, De Louvois J.Candida vaginitisPostgrad Med J1979; 55645–647
- Sobel JD.Pathogenesis and epidemiology of vulvovaginal candidiasisAnn NY Acad Sci1988; 544547–557
- Sobel JD.Pathogenesis and treatment of recurrent vulvovaginal candidiasisClin Infect Dis1992; 14S148–S153
- Fidel PL, Jr, Sobel JD.Immunopathogenesis of recurrent vulvovaginal candidiasisClin Microbiol Rev1996; 9335–348
- Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH.Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndromeN Engl J Med1984; 311354–357
- Fidel PL, Jr, Lynch ME, Sobel JD.Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasisInfect Immun1994; 621032–1038
- Fidel PL, Jr, Lynch ME, Conaway DH, Tait L, Sobel JD.Mice immunized by primary vaginal C. albicans infection develop acquired vaginal mucosal immunityInfect Immun1995; 63547–553
- Fidel PL, Jr, Luo W, Steele C, Chaiban J, Baker M, Wormley FL.Analysis of vaginal cell populations during experimental vaginal candidiasisInfect Immun1999; 673135–3140
- Wormley FL, Jr, Chaiban J, Fidel PL., JrCell adhesion molecule and lymphocyte activation marker expression during experimental vaginal candidiasisInfect Immun2001; 695072–5079
- Wormley FL, Jr, Steele C, Wozniak K, Fujihashi K, McGhee JR, Fidel PL., JrResistance of TCR δ-chain knock-out mice to experimental Candida vaginitisInfect Immun2001; 697162–7164
- Letterio JJ, Roberts AB.Regulation of immune responses by TGF-βAnn Rev Immunol1998; 16137–161
- Ludviksson BR, Seegers D, Resnick AS, Strober WThe effect of TGF-β on immune responses of naive versus memory CD4+ Thl/Th2 T cellsEur J Immunol2000; 302101–2111
- Fidel PL, Jr, Barousse M, Espinosa T, Chesson RR, Dunlap K.Local immune responsiveness following intravaginal challenge with Candida antigen in adult women at different stages of the menstrual cycleMed Mycol2003; 4197–109
- Taylor BN, Saavedra M, Fidel PL., JrLocal Thl/Th2 cytokine production during experimental vaginal candidiasisJ Med Mycol2000; 38419–431
- Fidel PL, Jr, Ginsburg KA, Cutright JL, Wolf NA, Leaman D, Dunlap K, Sobel JD.Vaginal-associated immunity in women with recurrent vulvovaginal candidiasis: Evidence for vaginal Thl-type responses following intravaginal challenge with Candida antigenJ Infect Dis1997; 176728–739
- Fidel PL, Jr, Lynch ME, Sobel JD.Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasisInfect Immun1993; 611990–1995
- Domer JE, Garner RE, Befidi-Mengue RN.Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMIInfect Immun1989; 57693–700
- Fidel PL, Jr, Wolf NA, KuKuruga MA.T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the peripheryInfect Immun1996; 643793–3799
- Fidel PL, Jr, Lynch ME, Sobel JD.Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasisInfect Immun1995; 632403–2408
- Brandtzaeg P.Mucosal immunity in the female genital tractJ Reprod Immunol1997; 3623–50
- Cardenas-Freytag L, Steele C, Wormley FL, Jr, Cheng E, Clements JD, Fidel PL, JrPartial protection against experimental vaginal candidiasis after mucosal vaccination with heat-killed Candida albicans and the mucosal adjuvant LT(R192G)Med Mycol2002; 40291–300
- Gould DS, Ploegh HL, Schust DJ.Murine female reproductive tract intraepithelial lymphocytes display selection characteristics distinct from both peripheral and other mucosal T cellsJ Reprod Immunol2001; 5285–99
- Cantorna MT, Mook D, Balish E.Resistance of congenitally immunodeficient gnotobiotic mice to vaginal candidasisInfect Immun1990; 583813–3815
- Black CA, Eyers FM, Russell A, Dunkley ML, Clancy RL, Beagley KW.Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytesJ Reprod Immunol1999; 451–18
- Fidel PL, Jr, Lynch ME, Redondo-Lopez V, Sobel JD, Robinson R.Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis (RVVC)J Infect Dis1993; 1681458–1465
- Leigh JE, Barousse M, Swoboda RK, et alCandida–specific systemic cell-mediated immune reactivities in HIV-infected persons with and without mucosal candidiaisisJ Infect Dis2001; 183277–285
- Fidel PL, Jr, Cutright JL, Sobel JD.Effects of systemic cell-mediated immunity on vaginal candidiasis in mice resistant and susceptible to Candida albicans infectionsInfect Immun1995; 634191–4194
- Mulero-Marchese RD, Blank KJ, Sieck TG.Genetic basis for protection against experimental vaginal candidiasis by peripheral immunizationJ Infect Dis1998; 178227–234
- De Bernardis F, Santoni G, Boccanera M, et alLocal anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicansInfect Immun2000; 683297–3304
- Cassone A, Boccanera M, Adriani DA, Santoni G, De Bernardis F.Rats clearing a vaginal infection by Candida albicans acquire specific, antibody-mediated resistance to vaginal infectionInfect Immun1995; 632619–2624
- Bernardis F, Boccanera M, Adriani D, Spreghini E, Santoni G, Cassone A.Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in ratsInfect Immun1997; 653399–3405
- Hawkins RA, Rank RG, Kelly KA.Expression of mucosal homing receptor α4β7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivoInfect Immun2000; 685587–5594
- Kelly KA, Rank RG.Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatisInfect Immun1997; 655198–5208
- Milligan GN, Bernstein DI.Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tractVirology1997; 229(1)259–268